Head and Neck Cancer of Unknown Primary · Symptoms & diagnosis

How is head and neck cancer of unknown primary diagnosed and staged?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Head and Neck Cancer of Unknown Primary Answer length: short, citable
Quick answer

Diagnosis requires a tissue biopsy read by a head and neck pathologist, supported by endoscopic examination and contrast CT or MRI of the neck; PET-CT is added when nodal or distant spread is suspected. Staging uses the AJCC TNM system and guides whether surgery, radiotherapy, chemoradiotherapy or systemic therapy is the primary treatment.

In detail

When the primary remains occult, staging is based on nodal burden (number, size, laterality), p16/HPV or EBV status and distant metastasis. Under AJCC 8, p16-positive node-positive disease without an identified primary is generally managed along the HPV-mediated oropharyngeal pathway rather than as a generic metastatic cancer.

Before radiotherapy, guidelines recommend a dental assessment and extraction of teeth with a poor prognosis inside the radiation field. Ask for this early: it prevents osteoradionecrosis later.

  • Fine-needle aspiration (FNA) or core biopsy of the neck node — never an open excisional biopsy as the first step
  • p16 immunohistochemistry and confirmatory HPV DNA/RNA testing on the node specimen; EBER/EBV testing when NPC is possible
  • Complete head and neck examination including flexible nasopharyngolaryngoscopy, oral cavity, scalp, ear and skin
  • Contrast CT and/or MRI of the neck; FDG PET-CT before or after examination under anaesthesia
  • Examination under anaesthesia with panendoscopy, bilateral palatine tonsillectomy and/or TORS base-of-tongue mucosectomy
  • Thyroid, salivary gland and cutaneous assessment when histology is not squamous cell carcinoma

What this means in practice: this answer is part of the “Symptoms & diagnosis” section of the Head and Neck Cancer of Unknown Primary topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about head and neck cancer of unknown primary

See all 13 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  3. HPV & Oropharyngeal Cancer US National Institute of Dental and Craniofacial Research · 2025 · About 70% of oropharyngeal cancers in the United States are HPV-positive.
  4. HPV Detection in Oropharyngeal Cancer: A Narrative Review PubMed Central / peer-reviewed review · 2025 · HPV-attributable fraction: ~71% US, ~52% UK, >60% Scandinavia, <20% Southern Europe, ~44% globally.
  5. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  6. Head and Neck Cancers (patient information) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.